Unclaimed Scholar Profile
Are you Tony R. Reid? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Epicentre (South Africa)ASIDASID-5090-7780-0480 orcid.org/0000-0003-1485-7470
Tony R. Reid
Epicentre (South Africa)•South Africa
Faculty researcher at Epicentre (South Africa) (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Virus-based gene therapy research#Colorectal Cancer Treatments and Studies#Immunotherapy and Immune Responses#Cancer Immunotherapy and Biomarkers
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 8,632 | 4,143 |
| h-index | 41 | 31 |
| i10-index | 119 | 83 |
Annual Citation Growth
Verified Citations / Year0
2020414
2021+40%580
2022+29%746
2023+33%994
2024-8%911
2025-45%497
2026Scholarship Distribution & Proportions244 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (7,078) • 18% Global Research Impact (1,554)
244 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (244)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Published in Nature Medicine•2013
DOI: 10.1038/nm.3089 Verified Peer-Reviewed
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Published in Journal of Clinical Oncology•2009
DOI: 10.1200/jco.2009.24.3675 Verified Peer-Reviewed
A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.
Published in PubMed•2003
A Review of Persistent Post-COVID Syndrome (PPCS)
Published in Clinical Reviews in Allergy & Immunology•2021
DOI: 10.1007/s12016-021-08848-3 Verified Peer-Reviewed
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
Published in PubMed•2000
Showing 1 – 5 of 244 publications
1 / 49